These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 33632724

  • 1. Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study.
    Keshavarzi S, Braffett BH, Pop-Busui R, Orchard TJ, Soliman EZ, Lorenzi GM, Barnie A, Karger AB, Gubitosi-Klug RA, Dagogo-Jack S, Paterson AD, DCCT/EDIC Research Group.
    Diabetes Care; 2021 May; 44(5):1125-1132. PubMed ID: 33632724
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Pop-Busui R, Braffett BH, Zinman B, Martin C, White NH, Herman WH, Genuth S, Gubitosi-Klug R, DCCT/EDIC Research Group.
    Diabetes Care; 2017 Jan; 40(1):94-100. PubMed ID: 27803120
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Realising the long-term promise of insulin therapy: the DCCT/EDIC study.
    Nathan DM.
    Diabetologia; 2021 May; 64(5):1049-1058. PubMed ID: 33550441
    [Abstract] [Full Text] [Related]

  • 8. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.
    Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group.
    Diabetes Care; 2016 May; 39(5):686-93. PubMed ID: 26861924
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Polak JF, Backlund JY, Cleary PA, Harrington AP, O'Leary DH, Lachin JM, Nathan DM, DCCT/EDIC Research Group.
    Diabetes; 2011 Feb; 60(2):607-13. PubMed ID: 21270271
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study.
    Gubitosi-Klug RA, Braffett BH, White NH, Sherwin RS, Service FJ, Lachin JM, Tamborlane WV, Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
    Diabetes Care; 2017 Aug; 40(8):1010-1016. PubMed ID: 28550194
    [Abstract] [Full Text] [Related]

  • 14. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Lachin JM, Orchard TJ, Nathan DM, DCCT/EDIC Research Group.
    Diabetes Care; 2014 Aug; 37(1):39-43. PubMed ID: 24356596
    [Abstract] [Full Text] [Related]

  • 15. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, Cleary PA, Waberski BH, Lachin JM, Diabetes Control and Complications Trial /Epidemiology of Diabetes Interventions and Complications Research Group.
    Diabetes Care; 2010 May; 33(5):1090-6. PubMed ID: 20150297
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk Factor Modeling for Cardiovascular Disease in Type 1 Diabetes in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study: A Comparison With the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC).
    Miller RG, Costacou T, Orchard TJ.
    Diabetes; 2019 Feb; 68(2):409-419. PubMed ID: 30409781
    [Abstract] [Full Text] [Related]

  • 19. Coprogression of Cardiovascular Risk Factors in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.
    Writing Group for the DCCT/EDIC Research Group.
    Diabetes Care; 2016 Sep; 39(9):1621-30. PubMed ID: 27436274
    [Abstract] [Full Text] [Related]

  • 20. Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.
    Sousa GR, Pober D, Galderisi A, Lv H, Yu L, Pereira AC, Doria A, Kosiborod M, Lipes MA.
    Circulation; 2019 Feb 05; 139(6):730-743. PubMed ID: 30586738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.